Caitlin Reed is an Infectious Disease physician affiliated with Centers for Disease Control and Prevention. OpenAlex indexes 19 publications with 1,093 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
14445 Olive View Dr
Olive View-Ucla Med Ctr, Dept Of Med, 2b-182
Sylmar, CA 913421437
Telephone
818-364-3205Provider last certified this registry record 3 Feb 2026.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20241 payment
- Boston Scientific CorporationProgram year20232 payments
- Astellas Pharma US IncProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Diarylquinoline Antimycobacterial100%Sirturo100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022–2024
Open Forum Infectious Diseases
2025 - Curated cases from the TB expert network: Unplugged! Series: Use of plasma microbial cell-free DNA metagenomic sequencing to diagnose Mycobacterium tuberculosis
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Alicia Fry
Centers for Disease Control and Prevention
Matthew D. Ritchey
Centers for Disease Control and Prevention
Marc Fischer
Centers for Disease Control and Prevention
Lorenzo Botto, MD
Centers for Disease Control and Prevention
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”